These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 205889)

  • 41. Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.
    Gumulka SW; Dinnendahl V; Peters HD; Schönhöfer PS
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 293(1):75-80. PubMed ID: 181689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Action in vitro and in vivo of chlorpromazine and haloperidol on cyclic nucleotide systems in mouse cerebral cortex and cerebellum.
    Palmer GC; Jones DJ; Medina MA; Palmer SJ; Stavinoha WB
    Neuropharmacology; 1978 Jul; 17(7):491-8. PubMed ID: 211456
    [No Abstract]   [Full Text] [Related]  

  • 43. Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II.
    Torres VE; Northrup TE; Edwards RM; Shah SV; Dousa TP
    J Clin Invest; 1978 Dec; 62(6):1334-43. PubMed ID: 219028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopaminephilic properties of ergot alkaloids.
    Goldstein M; Lew JY; Nakamura S; Battista AF; Lieberman A; Fuxe K
    Fed Proc; 1978 Jun; 37(8):2202-6. PubMed ID: 26607
    [No Abstract]   [Full Text] [Related]  

  • 45. [The role of the components of the cyclic nucleotide system in N-nitrosodiethylamine-induced hepatic carcinogenesis in rats].
    Antonenko SG; Berdinskikh NK; Mishnaevskaia EG
    Eksp Onkol; 1990; 12(5):18-21. PubMed ID: 2171896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.
    Giorgi M; D'Angelo V; Esposito Z; Nuccetelli V; Sorge R; Martorana A; Stefani A; Bernardi G; Sancesario G
    Eur J Neurosci; 2008 Sep; 28(5):941-50. PubMed ID: 18717735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons.
    Lin DT; Fretier P; Jiang C; Vincent SR
    Synapse; 2010 Jun; 64(6):460-6. PubMed ID: 20175220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
    Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
    Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adaptive changes of the striatal dopamine system induced by repeated administration of neuroleptics and ergot derivatives.
    Bürki HR
    Adv Biochem Psychopharmacol; 1980; 24():65-8. PubMed ID: 6105806
    [No Abstract]   [Full Text] [Related]  

  • 52. Increase in rat striatal acetylcholine content by bromocriptine: evidence for an indirect dopaminergic action.
    Consolo S; Ladinsky H; Pugnetti P; Fusi R; Crunelli V
    Life Sci; 1981 Aug; 29(5):457-65. PubMed ID: 7278497
    [No Abstract]   [Full Text] [Related]  

  • 53. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
    Fuxe K; Fredholm BB; Agnati LF; Ogren SO; Everitt BJ; Jonsson G; Gustafsson JA
    Pharmacology; 1978; 16 Suppl 1():99-134. PubMed ID: 643908
    [No Abstract]   [Full Text] [Related]  

  • 54. Dopamine-mimetic activity of ergot derivatives, as measured by the production of cyclic AMP in isolated retinae of the rabbit.
    Schorderet M
    Gerontology; 1978; 24 Suppl 1():86-93. PubMed ID: 201543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA; Kuczenski R
    Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the role of cyclic nucleotides in tumor of human nervous tissue: an overview.
    Frattola L; Cerri C; Villani R; Trabucchi M
    J Neurosurg Sci; 1979; 23(4):257-63. PubMed ID: 44883
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old and aged rats.
    Schmidt MJ; Thornberry JF
    Brain Res; 1978 Jan; 139(1):169-77. PubMed ID: 202373
    [No Abstract]   [Full Text] [Related]  

  • 58. [Interconnected biochemical processes in striatal neurons induced by activation of excitatory, inhibitory, and dopamine inputs].
    Sil'kis IG
    Ross Fiziol Zh Im I M Sechenova; 2000 May; 86(5):507-18. PubMed ID: 10885013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of narcotic dependence and withdrawal on striatal dopamine-sensitive adenylate cyclase and synaptosomal cyclic AMP metabolism.
    Merali Z; Tsang B; Singhal RL; Hrdina PD
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):29-37. PubMed ID: 180579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanism.
    Biggio G; Guidotti A
    Nature; 1977 Jan; 265(5591):240-2. PubMed ID: 189208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.